Abstract
Two genres of outcry in the US concerning the current state of science in public life need to be connected. One is politicization of science in regulatory and research agencies of the federal government; the other is commercialization of academic research. Since the 1990s, commercially funded think tanks have been the primary source for politically charged science policy. But continuing commercialization of academic research threatens to make universities and federal research institutions look similarly political. This development undermines public trust in science, which presents a fundamental challenge for democratic societies. Like the free press and the independent judiciary, trustworthy knowledge is fundamental to the responsible action of informed citizens and their legislators. Its preservation, however, cannot lie in any attempt to recover a strong divide between pure/academic and applied/industrial research. Commercialization is inevitable. To nevertheless mitigate the erosion of public trust, new institutions of evaluative oversight will be required, whether as academic/industrial collaborations or as federal agencies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
- 2.
- 3.
- 4.
- 5.
The papers collected in Grandin et al. (2004) provide a thorough critique of the pure-to-applied and university-to-industry model, or the “linear model.”
- 6.
Forman worries that the cultural primacy of technology is justifying the view that ends justify means, as opposed to the principle long established in democratic societies that ends must be judged in terms of the means for accomplishing them. Current political developments countenance the worry, as in the Bush administration’s arguments for torture, but I am skeptical that technology is the culprit.
- 7.
For example, the University of California has drafted a Health Care Vendor Relations Policy, emanating from the Office of the Provost and Executive Vice President and dated 25 January 2008, that sets minimum standards for its ten campuses. Supported by a bibliography of six articles in respected medical journals, the Univeristy recognizes that “A growing body of research has consistently demonstrated that nominal gifts from vendors [e.g., drug makers], heretofore thought to be innocuous, unconsciously affect provider [physicians’] behavior,” and is attempting to find a compromise, prohibiting obvious abuses such as gifts to individuals while allowing donations that support its mission. Allowed exceptions include educational donations, competitive prizes, research donations, and “honoraria for a specific service rendered” (e.g., delivering a speech, which can be a large exception). Research contracts, consulting fees, royalties, and stock ownership are not controlled, except in the requirement of disclosure.
- 8.
http://www.gene.com/gene/about/management/exec/levinson.jsp. Princeton, Spring 2006, 6.
- 9.
http://hdl.handle.net/1721.1/32982. Public Draft of the Declaration of the Second International Meeting on Synthetic Biology.
- 10.
See the Union of Concerned Scientists at http://www.ucsusa.org/scientific_integrity/restoring/scientific-advice.html. The Federation of American Scientists has launched a new archive of OTA documents at http://fas.org/ota/, which also contains a widely distributed video interview with Rush Holt, http://fas.org/ota/2008/07/23/watch-rush-holt-talk-about-ota/. Princeton University is host to an archive containing all formally issues reports of the OTA and other documents at http://www.princeton.edu/~ota/.
References
Abramson, J. 2006. Drug profits infect medical studies. Los Angeles Times, 7 January.
Armstrong, D. 2006. Critical dose: Aspirin dispute is fueled by funds of industry rivals; A cheap remedy for clotting used by millions of patients is undermined by research; Bayer’s friends fight back. Wall Street Journal (Eastern Edition), 24 April.
Baker, D. et al. 2006. Engineering life: Building a FAB for biology. Scientific American 294(6):44–51.
Bok, D. 2003. Universities in the Marketplace: The Commercialization of Higher Education. Princeton, NJ: Princeton University Press.
Bush, V. 1990. Science – The Endless Frontier: A Report to the President on a Program for Postwars Scientific Research. Washington, DC: National Science Foundation.
Campbell, E.G. et al. 2006. Financial relationships between institutional review board members and industry. New England Journal of Medicine 355:2321–2329.
Cone, M. 2008. EPA may decide not to limit toxin. Los Angeles Times, 7 May.
Creager, A., E. Lunbeck, and M.N. Wise (eds.). 2007. Science Without Laws: Model Systems, Cases, and Exemplary Narratives. Durham, NC: Duke University Press.
Dana, J. 2003. A social science perspective on gifts to physicians from industry. Journal of the American Medical Association 290:252–255.
Delbanco, A. 2007. Academic business: Has the modern university become just another corporation? New York Times Magazine, 30 September: 25–29.
Doctorow, E.L. 2008. The white whale. In The Public Good: Knowledge as the Foundation for a Democratic Society, 76–82. Cambridge, MA: AAAS.
Finder, A. 2008. At one university, tobacco money is secret. New York Times, 22 May.
Forman, P. 2007. The primacy of science in modernity, of technology in postmodernity, and of ideology in the history of technology. History and Technology 23:1–152.
Galison, P. 2003. Einstein’s Clocks, Poincaré’s Maps: Empires of Time. New York, NY and London: Norton.
Gellene, D. 2006. Financial ties found among clinical trials. Los Angeles Times, 30 November.
Grandin, K., S. Widmalm, and N. Wormbs (eds.). 2004. The Science-Industry Nexus: History, Policy, Implications. Sagamore Beach, MA: Science History Publications.
Harris, G., and B. Carey. 2008. Researchers fail to reveal full drug pay. New York Times, 8 June.
Johnson, A. 2004. The end of pure science: Science policy from Bayh-Dole to the NNI. In Discovering the Nanoscale, eds. D. Baird, A. Nordmann, and J. Schummer, 217–230. Amsterdam: IOS Press.
Krimsky, S. 2003. Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? Lanham, MD: Rowman and Littlefield.
Laughlin, R.B. 2005. A Different Universe: Reinventing Physics from the Bottom Down. New York, NY: Basic Books.
Laughlin, R.B., and D. Pines. 2000. The theory of everything. Proceedings of the National Academy of Sciences 97:28–31.
Mooney, C. 2005. The Republican War on Science. New York, NY: Basic Books.
Mowery, D.C. et al. 2004. Ivory Tower and Industrial Innovation: University-Industry Technology Transfer Before and After Bayh-Dole. Stanford, CA: Stanford University Press.
National Research Council of the National Academies 2006. Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues, p. 3. Washington, DC: National Academies Press.
Ober, J. 2008. Democracy and Knowledge: Learning and Innovation in Classical Athens. Princeton, NJ: Princeton University Press.
Pasternak, J. 2008. Hundreds of EPA scientists report political interference. Los Angeles Times, 24 April.
Randel, D.M. 2008. The public good: Knowledge as the foundation of a democratic society. In The Public Good: Knowledge as the Foundation for a Democratic Society, 9–12. Cambridge, MA: AAAS.
Rapoport, A.I. 2006. Where has all the money gone? Declining industrial support of academic R&D. InfoBrief: Science Services Statistics. NSF 06-328.
Revkin, A. 2008. NASA office is criticized on climate reports. New York Times, 3 June.
Rowland, H. 1902. A plea for pure science. Science 2 (1883):242–250. Reprinted in The Physical Papers of Henry Augustus Rowland. Baltimore, MD: Johns Hopkins Press.
Salgado, B. 2008. A hormonal seesaw: The atrazine and AI connection. Breast Cancer Action Source Newsletter 101 (April/May):6–7.
Schwedt, G. 2002. Liebig und seine Schüler – Die neue Schule der Chemie. Berlin: Springer.
Smith, C., and M.N. Wise. 1989. Energy and Empire: A Biographical Study of Lord Kelvin. Cambridge, UK: Cambridge University Press.
Vartabedian, R. 2006a. How environomentalists lost the battle over TCE. Los Angeles Times, March 29.
Vartabedian, R. 2006b. Is cancer stalking a ‘toxic triangle’? Los Angeles Times, March 30.
Weiner, C. 1986. Universities, professors, and patents: A continuing controversy. Technology Review (February/March).
Wiener, N. 1993. (written 1950s). Invention: The Care and Feeding of Ideas. Cambridge, MA: MIT Press.
Winters, K.H. 2008. Investigative summary regarding allegations that NASA suppressed climate change science and denied media access to Dr. James E. Hansen, a NASA scientist. NASA (National Aeronautics and Space Administration), Office of Inspector General. http://oig.nasa.gov/investigations/OI_STI_Summary.pdf.
Wise, M.N. (ed.). 2004. Growing Explanations: Historical Perspectives on Recent Science. Durham, NC: Duke University Press.
Acknowledgments
An earlier version of this paper appeared in Social Research, 73 (2006), 1253–1272. For their very helpful suggestions I thank organizer Tiago Saraiva and commentators Manuel Villaverde Cabral and João Caraça at an HoST Lecture at the Institute of Social Sciences, University of Lisbon; the participants in the Graduiertenkolleg of the Institut für Wissenschafts- und Technikforschung at the University of Bielefeld; and Elaine Wise, Lorraine Daston, Sally Gibbons, Theodore Porter, Suman Seth, and Otto Sibum.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Wise, M.N. (2011). Thoughts on Politicization of Science Through Commercialization. In: Carrier, M., Nordmann, A. (eds) Science in the Context of Application. Boston Studies in the Philosophy of Science, vol 274. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9051-5_17
Download citation
DOI: https://doi.org/10.1007/978-90-481-9051-5_17
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9050-8
Online ISBN: 978-90-481-9051-5
eBook Packages: Humanities, Social Sciences and LawPhilosophy and Religion (R0)